Nuclear medicine techniques are becoming more important in imaging oncological and infectious diseases. For metabolic imaging of these diseases, antibody and peptide imaging are currently used. In recent years peptide imaging has become important, therefore the rationale for the use of peptide imaging is described in this article. Criteria for a successful peptide tracer are a high target specificity, a high binding affinity, a long metabolic stability and a high target-to-background ratio. Tracer internalization is also beneficial. For oncological imaging, many tracers are available, most originating from regulatory peptides, but penetrating peptides are also being developed. Peptides for imaging inflammatory and infectious diseases includ...
Nuclear medicine techniques for imaging inflammation have had huge progress and have enormously expa...
The specificity of a diagnostic assay depends upon the purity of the biomolecules used as a probe. T...
Radiolabelled peptides are used for specific targeting of receptors (over-)expressed by tumour cells...
Nuclear medicine techniques are becoming more important in imaging oncological and infectious diseas...
The specificity of a diagnostic assay depends upon the purity of the biomolecules used as a probe. T...
Radiolabeled peptides can deliver radiation selectively to tumors via targeting peptide receptors th...
Molecular imaging consists of non-invasive monitoring of spatial-temporal distribution of molecular ...
Scientists are looking for new therapies to cope with the rise in cancer worldwide. Since cancer cel...
Radiolabelled peptides and monoclonal antibodies are an emerging class of radiopharmaceuticals for i...
Copyright © 2012 Muammad Saeed Akhtar et al. This is an open access article distributed under the Cr...
Contains fulltext : 49543.pdf (publisher's version ) (Open Access)Radiolabelled pe...
Antimicrobial peptides (AMPs) are a heterogeneous class of compounds found in a variety of organisms...
Infection specific radiopharmaceuticals can be used for diagnosis, decision-making in therapy and tr...
Item does not contain fulltextPeptide-based radiopharmaceuticals have been introduced into clinical ...
Item does not contain fulltextDuring the past decade, radiolabeled receptor-binding peptides have em...
Nuclear medicine techniques for imaging inflammation have had huge progress and have enormously expa...
The specificity of a diagnostic assay depends upon the purity of the biomolecules used as a probe. T...
Radiolabelled peptides are used for specific targeting of receptors (over-)expressed by tumour cells...
Nuclear medicine techniques are becoming more important in imaging oncological and infectious diseas...
The specificity of a diagnostic assay depends upon the purity of the biomolecules used as a probe. T...
Radiolabeled peptides can deliver radiation selectively to tumors via targeting peptide receptors th...
Molecular imaging consists of non-invasive monitoring of spatial-temporal distribution of molecular ...
Scientists are looking for new therapies to cope with the rise in cancer worldwide. Since cancer cel...
Radiolabelled peptides and monoclonal antibodies are an emerging class of radiopharmaceuticals for i...
Copyright © 2012 Muammad Saeed Akhtar et al. This is an open access article distributed under the Cr...
Contains fulltext : 49543.pdf (publisher's version ) (Open Access)Radiolabelled pe...
Antimicrobial peptides (AMPs) are a heterogeneous class of compounds found in a variety of organisms...
Infection specific radiopharmaceuticals can be used for diagnosis, decision-making in therapy and tr...
Item does not contain fulltextPeptide-based radiopharmaceuticals have been introduced into clinical ...
Item does not contain fulltextDuring the past decade, radiolabeled receptor-binding peptides have em...
Nuclear medicine techniques for imaging inflammation have had huge progress and have enormously expa...
The specificity of a diagnostic assay depends upon the purity of the biomolecules used as a probe. T...
Radiolabelled peptides are used for specific targeting of receptors (over-)expressed by tumour cells...